Chip Diagnostics

Chip Diagnostics aims to enable minimally invasive diagnostics and drug efficacy prediction and monitoring using a nanoscale liquid biopsy technique targeting extracellular vesicles (EVs). Chip Diagnostics aims to personalize patient therapy on a robust, easy-to-use platform positioned to become the leading EV-based solution for application in a variety of diseases. Provided with Chip’s proprietary technologies that combine EV miRNA data, clinicians will be empowered to diagnose earlier and choose more appropriate therapies, lengthening lives while reducing healthcare costs.

Joshua Buser, VP of Research & Development